Predicting response to cardiac resynchronization therapy: Use of strict left bundle branch block criteria.


Journal

Pacing and clinical electrophysiology : PACE
ISSN: 1540-8159
Titre abrégé: Pacing Clin Electrophysiol
Pays: United States
ID NLM: 7803944

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 02 12 2018
revised: 25 01 2019
accepted: 08 02 2019
pubmed: 20 2 2019
medline: 18 12 2019
entrez: 20 2 2019
Statut: ppublish

Résumé

Cardiac resynchronization therapy (CRT) reduces morbidity and mortality in heart failure with reduced ejection fraction (HFrEF). CRT efficacy is greater in left bundle branch block (LBBB). This study aimed to determine if strict LBBB criteria predict an improved QRS duration and left ventricular ejection fraction (LVEF) response after CRT. HFrEF patients who received a CRT device at a single quaternary center were included. Patients were divided into three groups based on baseline QRS morphology. Group 1 consisted of patients with strict LBBB. Group 2 had conventional LBBB, and group 3 had non-LBBB morphology. Outcomes assessed included change in QRS duration after CRT, change in LVEF, and all-cause mortality. In 231 patients, 56% of patients were in group 1, 29% were in group 2, and 15% were in group 3. Patients with strict LBBB had a significant reduction in QRS duration (-20.9 ± 12.4 ms) compared to conventional LBBB (6.7 ± 19.4 ms; P < 0.0001) and non-LBBB (3.9 ± 29.3 ms; P < 0.0001). Patients with strict LBBB had a significant increase in LVEF (19.5 ± 10.2) compared to conventional LBBB (5.3 ± 12.6; P < 0.0001) and non-LBBB (-1.3 ± 10.9; P < 0.0001). There was moderate negative correlation between changes in QRS duration and LVEF (correlation coefficient = -0.63, P < 0.0001). Strict LBBB criteria were associated with a significant reduction in mortality compared to conventional LBBB (odds ratio 0.49, 95% confidence interval 0.24 to 0.99; P = 0.046). Strict LBBB predicted a reduction in QRS duration and an increase in LVEF compared to conventional LBBB and non-LBBB morphology in patients with HFrEF who received CRT.

Sections du résumé

BACKGROUND BACKGROUND
Cardiac resynchronization therapy (CRT) reduces morbidity and mortality in heart failure with reduced ejection fraction (HFrEF). CRT efficacy is greater in left bundle branch block (LBBB). This study aimed to determine if strict LBBB criteria predict an improved QRS duration and left ventricular ejection fraction (LVEF) response after CRT.
METHODS METHODS
HFrEF patients who received a CRT device at a single quaternary center were included. Patients were divided into three groups based on baseline QRS morphology. Group 1 consisted of patients with strict LBBB. Group 2 had conventional LBBB, and group 3 had non-LBBB morphology. Outcomes assessed included change in QRS duration after CRT, change in LVEF, and all-cause mortality.
RESULTS RESULTS
In 231 patients, 56% of patients were in group 1, 29% were in group 2, and 15% were in group 3. Patients with strict LBBB had a significant reduction in QRS duration (-20.9 ± 12.4 ms) compared to conventional LBBB (6.7 ± 19.4 ms; P < 0.0001) and non-LBBB (3.9 ± 29.3 ms; P < 0.0001). Patients with strict LBBB had a significant increase in LVEF (19.5 ± 10.2) compared to conventional LBBB (5.3 ± 12.6; P < 0.0001) and non-LBBB (-1.3 ± 10.9; P < 0.0001). There was moderate negative correlation between changes in QRS duration and LVEF (correlation coefficient = -0.63, P < 0.0001). Strict LBBB criteria were associated with a significant reduction in mortality compared to conventional LBBB (odds ratio 0.49, 95% confidence interval 0.24 to 0.99; P = 0.046).
CONCLUSIONS CONCLUSIONS
Strict LBBB predicted a reduction in QRS duration and an increase in LVEF compared to conventional LBBB and non-LBBB morphology in patients with HFrEF who received CRT.

Identifiants

pubmed: 30779177
doi: 10.1111/pace.13638
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

431-438

Subventions

Organisme : Fonds de recherché du Quebec-Santé (FRQS)
Organisme : Fonds de recherché du Quebec-Santé

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Alexios Hadjis (A)

Department of Cardiology, McGill University Health Centre, Montreal, Quebec, Canada.

Ahmed AlTurki (A)

Department of Cardiology, McGill University Health Centre, Montreal, Quebec, Canada.

Riccardo Proietti (R)

Department of Cardiac, Thoracic and Vascular Sciences, University of Padua, Padua, Italy.

Mauricio Montemezzo (M)

Department of Cardiology, McGill University Health Centre, Montreal, Quebec, Canada.

Martin Bernier (M)

Department of Cardiology, McGill University Health Centre, Montreal, Quebec, Canada.

Jacqueline Joza (J)

Department of Cardiology, McGill University Health Centre, Montreal, Quebec, Canada.

Tomy Hadjis (T)

Department of Cardiology, McGill University Health Centre, Montreal, Quebec, Canada.
Department of Cardiology, Hôpital Sacré-Coeur de Montréal, Montreal, Quebec, Canada.

Vidal Essebag (V)

Department of Cardiology, McGill University Health Centre, Montreal, Quebec, Canada.
Department of Cardiology, Hôpital Sacré-Coeur de Montréal, Montreal, Quebec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH